Differentiation of endometrial stromal cells in vitro: Down-regulation of suppression of the cell cycle inhibitor p57 by HOXA10?

Molecular Human Reproduction

Volumn 11, Issue 4, 2005, Pages 245-251

  Qian, Kun ^a   Chen, Hong ^a   Wei, Yulan ^a   Hu, Juan ^a   Zhu, Guijin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Decidua; Embryonic implantation; Homeo box A10 protein; Human; p57KIP2

Indexed keywords

8 BROMO CYCLIC GMP; GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; PROTEIN P57;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DECIDUA; DECIDUALIZATION; DOWN REGULATION; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; NIDATION; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION; WESTERN BLOTTING;

CELL CYCLE; CELL DIFFERENTIATION; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DECIDUA; DNA-BINDING PROTEINS; DOWN-REGULATION; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; NUCLEAR PROTEINS; PREGNANCY; STROMAL CELLS; UP-REGULATION;

EID: 18644380160     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah147     Document Type: Article

References (50)

1. Arellano M and Moreno S (1997) Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol 29,559-573.
2. Bagot CN, Troy PJ and Taylor HS (2000) Alteration of maternal HOXA10 expression by in vivo gene transfection affects implantation. Gene Ther 7, 1378-1384.
3. Bamberger A, Sudahl S, Bamberger CM, Schulte HM and Loning T (1999) Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: implications for the control of proliferation. Placenta 20,401-406.
4. Blomhoff HK, Blomhoff R, Stokke T, DeLange Davies C, Brevik K, Smeland EB, Funderud S and Godal T (1988) cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1. J Cell Physiol 137,583-587.
5. Brosens JJ, Hayashi N and White JO (1999) Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 140,4809-4820.
6. Chellappan SP, Giordano A and Fisher PB (1998) Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol 227,57-103.
7. Christian M, Mak I, White JO and Brosens JJ (2002a) Mechanisms of decidualization. Reprod Biomed Online 4 (Suppl. 3),24-30.
8. Christian M, Pohnke Y, Kempf R, Gellersen B and Brosens JJ (2002b) Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol Endocrinol 16,141-154.
9. Daftary GS and Taylor HS (2000) Implantation in the human: the role of HOX genes. Semin Reprod Med 18,311-320.
10. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82,675-684.
11. Duboule D (1995) Vertebrate Hox genes and proliferation: an alternative pathway to homeosis? Curr Opin Genet Dev 5,525-528.
12. Dugan LL, Kim JS, Zhang Y, Bart RD, Sun Y, Holtzman DM and Gutmann DH (1999) Differential effects of cAMP in neurons and astrocytes. J Biol Chem 274,25842-25848.
13. Fukumoto S, Koyama H, Hosoi M, Yamakawa K, Tanaka S, Morii H and Nishizawa Y (1999) Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ Res 85,985-991.
14. Fukunaga M (2002) Immunohistochemical characterization of p57 (KIP2) expression in early hydatidiform moles. Hum Pathol 33,1188-1192.
15. Gao J, Mazella J and Tseng L (2002) Hox proteins activate the IGFBP-1 promoter and suppress the function of hPR in human endometrial cells. DNA Cell Biol 21,819-825.
16. Gellersen B and Brosens J (2003) Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 178,357-372.
17. Geum D, Sun W, Paik SK, Lee CC and Kim K (1997) Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3. Mol Reprod Dev 46,450-458.
18. Hashimoto Y, Kohri K, Kaneko Y, Morisaki H, Kato T, Ikeda K and Nakanishi M (1998) Critical role for the 310 helix region of p57 (Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression. J Biol Chem 273,16544-16550.
19. Hayashi S, Morishita R, Matsushita H, Nakagami H, Taniyama Y, Nakamura T, Aoki M, Yamamoto K, Higaki J and Ogihara T (2000) Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 35,237-243.
20. Head JR, MacDonald PC and Casey ML (1993) Cellular localization of membrane metalloendopeptidase (enkephalinase) in human endometrium during the ovarian cycle. J Clin Endocrinol Metab 76,769-776.
21. Hollenberg MD and Cuatrecasas P (1973) Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin. Proc Natl Acad Sci USA 70,2964-2968.
22. Kato JY, Matsuoka M, Polyak K, Massague J and Sherr CJ (1994) Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79,487-496.
23. Koshiyama M, Konishi I, Nanbu K, Nanbu Y, Mandai M, Komatsu T, Yamamoto S, Mori T and Fujii S (1995) Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: correlation with sex steroid receptors and Ki-67 antigen expression. J Clin Endocrinol Metab 80,1106-1112.
24. L'Allemain G, Lavoie JN, Rivard N, Baldin V and Pouyssegur J (1997) Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14,1981-1990.
25. Lee M-H, Reynisdottir I and Massague J (1995) Cloning of p57kip2, a cyclindependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9,639-649.
26. Lee MP, DeBaun M, Randhawa G, Reichard BA, Elledge SJ and Feinberg AP (1997) Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. Am J Hum Genet 61,304-309.
27. Luo Y, Hurwitz J and Massague J (1995) Cell cycle inhibition by independent CDK and PCNA binding domains in p21cip1. Nature 375,159-161.
28. Ma L, Benson GV, Lim H, Dey SK and Maas RL (1998) Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 197,141-154.
29. Mark MD and Storm DR (1997) Coupling of epidermal growth factor (EGF) with the antiproliferative activity of cAMP induces neuronal differentiation. J Biol Chem 272,17238-17244.
30. Massague J, Blain SW and Lo RS (2000) TGFb signalling in growth control, cancer, and heritable disorders. Cell 103,295-309.
31. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW and Elledge SJ (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9,650-662.
32. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon LP and Conneely OM (2000) Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289,1751-1754.
33. Nilsson J and Olsson AG (1984) Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis 53,77-82.
34. Noyes RW, Hertig AT and Rock J (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122,262-265.
35. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW and Elledge SJ (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027.
36. Pavletich NP (1999) Mechanisms of cyclin-dependent kinase regulation: structure of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287,821-828.
37. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW and Sutherland RL (1997) Estrogen-induced activation of cdk4 and cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclinE-cdk2. J Biol Chem 272,10882-10894.
38. Reed SI, Billy E, Dulic V, Hengst L, Resnitzky D and Slingerland J (1994) G1 control in mammalian cells. J Cell Sci 18 (Suppl),69-73.
39. Ryan IP, Schriock ED and Taylor RN (1994) Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 78,642-649.
40. Shiozawa T, Nikaido T, Nakayama K, Lu X and Fujii S (1998) Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone. Mol Hum Reprod 4,899-905.
41. Tan J, Raja S, Davis MK, Tawfik O, Dey SK and Das SK (2002) Evidence for coordinated interaction of cyclinD3 with p21 and cdk6 in directing the development of uterine stromal cell decidualization and polyploidy during implantation. Mech Dev 111,99-113.
42. Taylor HS, Arici A, Olive D and Igarashi P (1998) HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 101,1379-1384.
43. Wang JD, Zhu JB, Shi WL and Zhu PD (1994) Immunocytochemical colocalization of progesterone receptor and prolactin in individual stromal cells of human decidua. J Clin Endocrinol Metab 79,293-297.
44. Wang H, Critchley HOD, Kelly RW, Shen D and Baird DT (1998) Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4,407-412.
45. Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J and Xiong Y (1998) Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 95,1392-1397.
46. Wewer UM, Faber M, Liotta LA and Albrechtsen R (1985) Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells. Lab Invest 53,624-633.
47. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO and Andersson S (1993) Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem 268,12964-12973.
48. Yao MW, Lim H, Schust DJ, Choe SE, Farago A, Ding Y, Michaud S, Church GM and Maas RL (2003) Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of Hoxa-10 in the preimplantation uterus. Mol Endocrinol 17,610-627.
49. Zhang P, Wong C, DePinho RA, Harper JW and Elledge SJ (1998) Cooperation between the Cdk inhibitors p27 (KIP1) and p57 (KIP2) in the control of tissue growth and development. Genes Dev 12,3162-3167.
50. Zhang P, Wong C, Liu D, Finegold M, Harper JW and Elledge SJ (1999) p21 (CIP1) and p57 (KIP2) control muscle differentiation at the myogenin step. Genes Dev 13,213-224.